We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer-BioNTech Release Favorable Results of COVID-19 Vaccine Study in 5- to 11-Year- Olds, Possibly Calming Turmoil at FDA
Pfizer-BioNTech Release Favorable Results of COVID-19 Vaccine Study in 5- to 11-Year- Olds, Possibly Calming Turmoil at FDA
Pfizer-BioNTech’s COVID-19 vaccine for kids age five to 11 years appears ready for prime time as the first results from the companies’ trial of a COVID-19 vaccine in this age group are released.